These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10481433)

  • 21. Structural basis for epibatidine selectivity at desensitized nicotinic receptors.
    Pennington RA; Gao F; Sine SM; Prince RJ
    Mol Pharmacol; 2005 Jan; 67(1):123-31. PubMed ID: 15496507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The locus coeruleus nucleus as a site of action of the antinociceptive and behavioral effects of the nicotinic receptor agonist, epibatidine.
    Cucchiaro G; Chaijale N; Commons KG
    Neuropharmacology; 2006 Jun; 50(7):769-76. PubMed ID: 16460769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epibatidine--a nicotine-related, analgesic alkaloid from poison-dart frogs].
    Müller CE
    Pharm Unserer Zeit; 1996 Apr; 25(2):85-92. PubMed ID: 8778816
    [No Abstract]   [Full Text] [Related]  

  • 24. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.
    Meyer MD; Decker MW; Rueter LE; Anderson DJ; Dart MJ; Kim KH; Sullivan JP; Williams M
    Eur J Pharmacol; 2000 Mar; 393(1-3):171-7. PubMed ID: 10771011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epibatidine isomers and analogues: structure-activity relationships.
    White R; Malpass JR; Handa S; Richard Baker S; Broad LM; Folly L; Mogg A
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5493-7. PubMed ID: 16934977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
    Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
    J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses of (+/-)-homoepibatidine analogues.
    Kim YH; Oh CY; Lee KY; Lee YS; Jung YH; Park HJ; Ham WH
    Arch Pharm Res; 2002 Feb; 25(1):49-52. PubMed ID: 11885691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syntheses and biological properties of cysteine-reactive epibatidine derivatives.
    Che C; Petit G; Kotzyba-Hibert F; Bertrand S; Bertrand D; Grutter T; Goeldner M
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1001-4. PubMed ID: 12643898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotinic acetylcholine receptors: an overview on drug discovery.
    D'hoedt D; Bertrand D
    Expert Opin Ther Targets; 2009 Apr; 13(4):395-411. PubMed ID: 19335063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators.
    Lightfoot AP; Kew JN; Skidmore J
    Prog Med Chem; 2008; 46():131-71. PubMed ID: 18381125
    [No Abstract]   [Full Text] [Related]  

  • 32. Analgetically active substances derived from structures of anpirtoline and epibatidine.
    Rádl S; Hezký P; Proska J; Krejcí I
    Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():26-9. PubMed ID: 9789748
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.
    Cheng J; Zhang C; Stevens ED; Izenwasser S; Wade D; Chen S; Paul D; Trudell ML
    J Med Chem; 2002 Jul; 45(14):3041-7. PubMed ID: 12086489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception.
    Flores CM; Wilson SG; Mogil JS
    Pharmacogenetics; 1999 Oct; 9(5):619-25. PubMed ID: 10591542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the alpha subunit on imidacloprid sensitivity of recombinant nicotinic acetylcholine receptors.
    Matsuda K; Buckingham SD; Freeman JC; Squire MD; Baylis HA; Sattelle DB
    Br J Pharmacol; 1998 Feb; 123(3):518-24. PubMed ID: 9504393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new look at the neuronal nicotinic acetylcholine receptor pharmacophore.
    Curtis L; Chiodini F; Spang JE; Bertrand S; Patt JT; Westera G; Bertrand D
    Eur J Pharmacol; 2000 Mar; 393(1-3):155-63. PubMed ID: 10771009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nature's agents help heal humans--some now take steps to reciprocate.
    Marwick C
    JAMA; 1998 Jun; 279(21):1679-81. PubMed ID: 9624009
    [No Abstract]   [Full Text] [Related]  

  • 38. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism.
    Eilers H; Schaeffer E; Bickler PE; Forsayeth JR
    Mol Pharmacol; 1997 Dec; 52(6):1105-12. PubMed ID: 9415721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-(2,5-Dihydro-1H-pyrrol-2-ylmethoxy)pyridines: synthesis and analgesic activity.
    Baraznenok IL; Jonsson E; Claesson A
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1637-40. PubMed ID: 15745813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics.
    Daly JW; Garraffo HM; Spande TF; Decker MW; Sullivan JP; Williams M
    Nat Prod Rep; 2000 Apr; 17(2):131-5. PubMed ID: 10821107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.